Lonza is confident that U.S. and Swiss plants it is building to help make Moderna's COVID19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.from Top Business News- News18.com https://ift.tt/2GlUM0x
Comments
Post a Comment